Dexrazoxane Hydrochloride and Ranibizumab ophthalmic
Determining the interaction of Dexrazoxane Hydrochloride and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Hydrochloride-Ranitidine
- Dexrazoxane Hydrochloride-Ranitidine Capsule
- Dexrazoxane Hydrochloride-Ranitidine Hydrochloride
- Dexrazoxane Hydrochloride-Ranitidine Injection
- Dexrazoxane Hydrochloride-Ranitidine Suspension
- Dexrazoxane Hydrochloride-Ranitidine Syrup
- Ranibizumab ophthalmic-Dexrazoxane Intravenous
- Ranibizumab ophthalmic-Dextenza Insert
- Ranibizumab ophthalmic-Dextenza intraocular
- Ranibizumab ophthalmic-Dextran 40
- Ranibizumab ophthalmic-Dextran 70 6% in 5% Dextrose high molecular weight
- Ranibizumab ophthalmic-Dextran 75